Taurine’s effects on healthspan and lifespan, Part 2
Four 2023 papers that cited Part 1, starting with a review of hypothetical parameters for taurine clinical trials that aren’t going to happen because: Drug companies can’t make money from a research area that’s cheap, not patentable, and readily accessible. Government sponsors are likewise not incentivized to act in the public’s interest per their recent … Continue reading Taurine’s effects on healthspan and lifespan, Part 2